 | X4 Pharmaceuticals Inc (NASDAQ:XFOR) Expected to Post Earnings of -$0.70 Per Share
www.americanbankingnews.com - May 22 at 4:24 PM |
 | Arsanis Inc (XFOR) Moves to Buy: Rationale Behind the Upgrade
finance.yahoo.com - May 13 at 1:57 PM |
| X4 Pharmaceuticals Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders
finance.yahoo.com - May 12 at 5:38 PM |
 | X4 Pharmaceuticals, Inc. (XFOR) CEO Paula Ragan on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 9:41 PM |
| X4 Pharmaceuticals (NASDAQ:XFOR) Announces Earnings Results
www.americanbankingnews.com - May 9 at 12:16 AM |
| HC Wainwright Trims X4 Pharmaceuticals (NASDAQ:XFOR) Target Price to $21.00
www.americanbankingnews.com - May 8 at 7:49 PM |
| B. Riley Lowers X4 Pharmaceuticals (NASDAQ:XFOR) Price Target to $15.00
www.americanbankingnews.com - May 8 at 7:49 PM |
| X4 Pharmaceuticals (NASDAQ:XFOR) Stock Rating Reaffirmed by Oppenheimer
www.americanbankingnews.com - May 7 at 8:09 PM |
| X4 Pharmaceuticals Provides Corporate Update, Including Expected Impact of COVID-19, and Reports First Quarter 2020 Financial Results
finance.yahoo.com - May 7 at 4:48 PM |
| Paula Ragan Sells 2,400 Shares of X4 Pharmaceuticals Inc (NASDAQ:XFOR) Stock
www.americanbankingnews.com - May 5 at 7:23 PM |
|
| X4 Pharmaceuticals Inc (NASDAQ:XFOR) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - May 3 at 6:14 AM |
| X4 Pharmaceuticals (XFOR) Scheduled to Post Quarterly Earnings on Thursday
www.americanbankingnews.com - April 30 at 6:35 AM |
| Zacks: Analysts Anticipate X4 Pharmaceuticals Inc (NASDAQ:XFOR) to Post -$0.83 Earnings Per Share
www.americanbankingnews.com - April 29 at 9:00 AM |
| X4 Pharmaceuticals to Announce First Quarter 2020 Financial Results and Provide Recent Business Highlights on May 7, 2020
finance.yahoo.com - April 23 at 12:13 PM |
| X4 Pharmaceuticals Showcases Strategic Focus on WHIM Syndrome During 2020 Analyst Day Webinar
finance.yahoo.com - April 7 at 3:57 PM |
 | X4 Pharmaceuticals Inc.
www.barrons.com - March 27 at 11:36 PM |
| X4 Pharmaceuticals to Host 2020 Analyst Day Webinar:
A Deep Dive into WHIM Syndrome
finance.yahoo.com - March 25 at 12:59 PM |
| Maryland biotech CEO: Virus outbreak won't stop opening of Boston R&D hub
finance.yahoo.com - March 20 at 9:00 AM |
| X4 Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2019 Financial Results
finance.yahoo.com - March 12 at 7:39 AM |
| X4 Pharmaceuticals (XFOR) Presents At Cowen Health Care Conference - Slideshow
seekingalpha.com - March 5 at 10:33 AM |
| X4 Pharmaceuticals to Announce Fourth Quarter and Full Year 2019 Financial Results and Provide Recent Business Highlights on March 12, 2020
finance.yahoo.com - February 27 at 12:24 PM |
| X4 Pharmaceuticals to Present at Two Upcoming Investor Conferences in March
finance.yahoo.com - February 25 at 8:59 AM |
| X4 Pharmaceuticals Granted New Composition of Matter Patent for Late-Stage Clinical Candidate Mavorixafor
finance.yahoo.com - February 12 at 3:11 PM |
| Street Watch: Top Analysts Make Moves on 3 Buy-Rated Stocks
finance.yahoo.com - December 26 at 11:40 AM |
| Hedge Funds Staying Clear Of X4 Pharmaceuticals, Inc. (XFOR)
finance.yahoo.com - December 20 at 6:21 PM |
| X4 Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy?
finance.yahoo.com - December 16 at 1:30 PM |
| B. Riley sees 146% upside in X4 Pharma in premarket analyst action
seekingalpha.com - December 5 at 12:28 PM |
| X4 Pharmaceuticals Enters Oversold Territory
finance.yahoo.com - December 3 at 1:06 PM |
| X4 Pharmaceuticals Prices $65 Million Public Offering of Common Stock and Class B Warrants
finance.yahoo.com - November 26 at 11:37 AM |
| X4 Pharmaceuticals Announces Proposed Public Offering
finance.yahoo.com - November 25 at 6:06 PM |
| X4 Pharmaceuticals Receives Breakthrough Therapy Designation from the FDA for Mavorixafor for the Treatment of WHIM Syndrome
finance.yahoo.com - November 12 at 12:00 PM |
| X4 Pharmaceuticals, Inc. (XFOR) CEO Paula Ragan on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 10 at 7:30 AM |
| X4 Pharmaceuticals EPS misses by $0.15
seekingalpha.com - November 7 at 8:07 AM |
| X4 Pharmaceuticals, Inc. to Host Earnings Call
finance.yahoo.com - November 7 at 8:07 AM |
| X4 Pharmaceuticals Reports Third Quarter 2019 Financial Results and Recent Business Highlights
finance.yahoo.com - November 7 at 8:07 AM |
| X4 Pharmaceuticals Initiates Phase 1b Clinical Trial of Mavorixafor for the Treatment of Severe Congenital Neutropenia
finance.yahoo.com - November 5 at 12:42 PM |
| X4 Pharmaceuticals Appoints Derek Meisner, J.D., as General Counsel
finance.yahoo.com - November 4 at 9:30 AM |
| X4 Pharmaceuticals to Announce Third Quarter 2019 Financial Results and Provide Recent Business Highlights on November 7, 2019
finance.yahoo.com - October 25 at 12:27 PM |
 | X4 Pharmaceuticals Reports Positive Data from...
www.benzinga.com - September 30 at 6:47 AM |
| X4 Pharmaceuticals Reports Positive Data from Phase 2a Trial of Mavorixafor in Combination with Axitinib in Advanced Clear Cell Renal Cell Carcinoma Patients
finance.yahoo.com - September 30 at 6:47 AM |
| X4 Pharmaceuticals Appoints Renato Skerlj, Ph.D. as Senior Vice President of Research and Development
finance.yahoo.com - September 18 at 8:43 AM |
| X4 Pharmaceuticals to Present Phase 2a Data for Mavorixafor in Combination with Axitinib at European Society for Medical Oncology (ESMO) 2019 Congress
finance.yahoo.com - September 12 at 12:03 PM |
| X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - August 18 at 8:38 AM |
| X4 Pharmaceuticals (XFOR) Presents At Canaccord Genuity Growth Conference - Slideshow
seekingalpha.com - August 13 at 3:25 PM |
| X4 Pharma's mavorixafor an Orphan Drug in Europe for rare immunodeficiency disorder; shares up 2%
seekingalpha.com - July 30 at 3:23 PM |
| X4 Pharmaceuticals Receives Orphan Drug Designation from European Commission for Mavorixafor for Treatment of WHIM Syndrome
finance.yahoo.com - July 30 at 9:07 AM |
| X4 Pharmaceuticals to Attend Two Upcoming Investor Conferences
finance.yahoo.com - July 24 at 3:23 PM |
| X4 Pharmaceuticals Initiates Pivotal Phase 3 Clinical Trial of Mavorixafor for the Treatment of WHIM Syndrome
finance.yahoo.com - June 26 at 3:18 PM |
| X4 Pharma to fund no-cost genetic testing for rare immune deficiency disorder; shares up 3%
seekingalpha.com - June 12 at 3:06 PM |
| X4 Pharmaceuticals Prices $85.8 Million Public Offering of Common Stock and Class A Warrants
finance.yahoo.com - May 22 at 8:37 AM |
